Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis

AIM: Patients with primary biliary cholangitis (PBC) have at least 60% probability of having an autoimmune extrahepatic condition, with the most common being Sjögren's syndrome (SS). The impacts of SS on the response and outcomes in ursodeoxycholic acid (UDCA)-treated patients with PBC, however...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Ping, Men, Ruoting, Shen, Mengyi, Wang, Tingting, Huang, Chen, Fan, Xiaoli, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582895/
https://www.ncbi.nlm.nih.gov/pubmed/31275901
http://dx.doi.org/10.1155/2019/7396870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582895/
https://www.ncbi.nlm.nih.gov/pubmed/31275901
http://dx.doi.org/10.1155/2019/7396870

Ejemplares similares